SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-21-251598
Filing Date
2021-08-19
Accepted
2021-08-19 16:50:15
Documents
12

Document Format Files

Seq Description Document Type Size
1 F-3 d71878df3.htm F-3 594396
2 EX-1.2 d71878dex12.htm EX-1.2 230325
3 EX-4.6 d71878dex46.htm EX-4.6 343315
4 EX-4.7 d71878dex47.htm EX-4.7 327578
5 EX-5.1 d71878dex51.htm EX-5.1 66429
6 EX-5.2 d71878dex52.htm EX-5.2 26400
7 EX-23.1 d71878dex231.htm EX-23.1 1655
8 GRAPHIC g71878g04p85.jpg GRAPHIC 30570
9 GRAPHIC g71878g0820005743131.jpg GRAPHIC 7226
10 GRAPHIC g71878g0820005743318.jpg GRAPHIC 6608
11 GRAPHIC g71878g51u63.jpg GRAPHIC 35270
12 GRAPHIC g71878g80q77.jpg GRAPHIC 3830
  Complete submission text file 0001193125-21-251598.txt   1699878
Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Filer) CIK: 0001709626 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-258941 | Film No.: 211190818
SIC: 2834 Pharmaceutical Preparations